Zeon Corporation, a world leader in specialty elastomers, polymers, and specialty chemicals, has reached agreement to acquire Aurora Microplates, a leading manufacturer and supplier of high-performance microplates. The official announcement was made in Tokyo today.  The acquisition is expected to be completed by February 28, 2022.

"We are very excited to enter the high-value high-performance microplate market. For more than 20 years we have supplied Aurora Microplates with polymer and film material for its microplates, and we are pleased to be able to enter the drug discovery research markets with a highly respected and knowledgeable partner" said Kimiaki Tanaka, President and CEO at Zeon Corporation.

The Aurora Microplates business fits into Zeon Corporation's strategy to deliver the best material and products to enable users involved in research and diagnostics to improve human health. Through Aurora Microplates, Zeon will support front-line scientists in their quest to better understand the subtle clues involved in animal and human health.

"We are thrilled to be working in complete synergy with Zeon, our resin and film supplier since Aurora was born more than 20 years ago" said Charles Powell, Managing Partner at Aurora Microplates, "this combination of raw material supplier and Microplate Manufacturer is unique in the marketplace- and will provide our current and future microplates users piece of mind with respect to microplate supply for their critical research needs."